PTC
ACOR

Private Trust Company’s Acorda Therapeutics ACOR Stock Holding History

Private Trust Company’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Hold
0
– -$1K – 1271
2014
Q3 		– Hold
0
– – – 1819
2014
Q2 		– Hold
0
– – – 1835
2014
Q1 		– Hold
0
– – – 1709
2013
Q4 		– Sell
-1
Closed -$3.9K – 1682
2013
Q3 		$2K Hold
1
– – ﹤0.01% 1473
2013
Q2 		$2K Buy
+1
New +$4.12K ﹤0.01% 1406

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Private Trust Company's ACOR Position: Q4 2014 in Review

Private Trust Company held its Acorda Therapeutics (ACOR) position steady in Q4 2014 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1271.

Private Trust Company first reported a position in ACOR in Q2 2013 and has held it in 2 quarters since. The position peaked at $2K in Q3 2013. 179 funds tracked by Wall St. Rank hold ACOR as of Q4 2014.

  • Private Trust Company held 0 shares of Acorda Therapeutics worth $0 as of Q4 2014.
  • Private Trust Company left its Acorda Therapeutics share count unchanged in Q4 2014.
  • Acorda Therapeutics made up ﹤0.01% of Private Trust Company's portfolio in Q4 2014, its #1271 holding.
  • Private Trust Company first reported a position in Acorda Therapeutics in Q2 2013 and has held it in 2 quarters since.
  • Private Trust Company's Acorda Therapeutics position peaked at $2K in Q3 2013.
  • 179 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2014.

Based on Private Trust Company's 13F filing for Q4 2014, filed 28 Jan 2015.